# Yoshitsugu Kojima

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yoshitsugu-kojima/

## Facts

| Field | Value |
| --- | --- |
| Citations | 110 |
| Field | Schizophrenia research and treatment |
| h-index | 6 |
| i10-index | 5 |
| Last Known Institution | Otsuka (Japan) |
| OpenAlex ID | https://openalex.org/A5101506759 |
| ORCID iD | 0000-0002-0286-8765 |
| Works | 19 |

## Researcher papers

- [Real-World Treatment Patterns and Adherence to Oral Medication Among Patients with Bipolar Disorders: A Retrospective, Observational Study Using a Healthcare Claims Database](https://scholariq.org/papers/real-world-treatment-patterns-and-adherence-to-oral-medication-among-patients/)
- [Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan](https://scholariq.org/papers/treatment-persistence-between-long-acting-injectable-versus-orally-administered/)
- [Effect of brexpiprazole on control of impulsivity in schizophrenia: A randomized functional magnetic resonance imaging study](https://scholariq.org/papers/effect-of-brexpiprazole-on-control-of-impulsivity-in-schizophrenia-a-randomized/)
- [Burden in caregivers of patients with schizophrenia, depression, dementia, and stroke in Japan: comparative analysis of quality of life, work productivity, and qualitative caregiving burden](https://scholariq.org/papers/burden-in-caregivers-of-patients-with-schizophrenia-depression-dementia-and/)
- [Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study](https://scholariq.org/papers/safety-of-switching-to-brexpiprazole-in-japanese-patients-with-schizophrenia-a/)
- [Post‐hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long‐term study (Secondary Publication)](https://scholariq.org/papers/post-hoc-analysis-investigating-the-safety-and-efficacy-of-brexpiprazole-in/)
- [Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective](https://scholariq.org/papers/cost-effectiveness-of-fremanezumab-in-episodic-and-chronic-migraine-patients/)
- [Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation study](https://scholariq.org/papers/efficacy-and-safety-of-tolvaptan-in-patients-with-malignant-ascites-a-phase-2/)
- [<p>Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study</p>](https://scholariq.org/papers/and-lt-p-and-gt-long-term-efficacy-and-safety-of-brexpiprazole-in-elderly/)
- [Clinical characteristics of patients with alcohol dependence comorbid with hypertension among regular drinkers: An internet-based, cross-sectional study in Japan](https://scholariq.org/papers/clinical-characteristics-of-patients-with-alcohol-dependence-comorbid-with/)

## Researcher topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)
- [Substance Abuse Treatment and Outcomes](https://scholariq.org/topics/substance-abuse-treatment-and-outcomes/)

## Researcher university

- [Otsuka (Japan)](https://scholariq.org/institutions/otsuka-japan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.